(Total Views: 340)
Posted On: 02/17/2020 10:03:46 AM
Post# of 11802
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
These last two PR's are big news in my opinion. I like how the PR on January 21st and the PR on February 4th dovetail together. Of course, the icing on the cake will be when the details of the license agreement are announced. Now that DECN has the "TBG Precise Meter" in hand, the company can move forward with the agreement. This is big news. Good luck, KB!
Quote:
Mr. Berman continued, "We are also pleased to announce that we have accepted the commercial version of the GenUltimate! TBG Precise meter. Under most circumstances this event would make for its own news release. However, while drafting this release we had a most interesting and happy occurrence. Pharma Tech has concluded two new partnerships that will provide further growth for our line of human and pet diabetic testing products. The first arrangement is with a national marketer of both pet and human products at both retail locations and on the web. The second is a national retailer with over 2000 locations in the U.S., Canada and Mexico. We will have product in both retail stores and on the retailer's popular web sites. These programs both will encompass 4-5 of our products, and will be sold under several brand names, including the name and brands of the large retailer.
Mr. Berman concluded, "We anticipate additional updates, in particular about our upcoming licensing agreement, in the coming days. This agreement awaited only the completion of the Precise meter."
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
Scroll down for more posts ▼